ImmunoGen Inc. Common Stock is a pharmaceutical company that focuses on developing targeted antibody-drug conjugates for the treatment of cancer. With a strong pipeline of innovative therapies, ImmunoGen aims to revolutionize cancer treatment by delivering powerful and precise therapeutics to patients in need.
Notification